Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Oct-Dec;39(4):562-563.
doi: 10.1016/j.ijmmb.2021.05.017. Epub 2021 Jun 4.

Breakthrough COVID-19 case after full-dose administration of CoronaVac vaccine

Zulvikar Syambani Ulhaq  1 , Gita Vita Soraya  2 , Kristin Indriana  3
Affiliations
Comment

Breakthrough COVID-19 case after full-dose administration of CoronaVac vaccine

Zulvikar Syambani Ulhaq et al. Indian J Med Microbiol. 2021 Oct-Dec.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest None.

Figures

Fig. 1
Fig. 1
Timeline of vaccine schedule, symptoms onset, COVID-19 diagnosis, and antibody measurement.
See this image and copyright information in PMC

Comment on

  • Vaccine Breakthrough Infections with SARS-CoV-2 Variants.
    Hacisuleyman E, Hale C, Saito Y, Blachere NE, Bergh M, Conlon EG, Schaefer-Babajew DJ, DaSilva J, Muecksch F, Gaebler C, Lifton R, Nussenzweig MC, Hatziioannou T, Bieniasz PD, Darnell RB. Hacisuleyman E, et al. N Engl J Med. 2021 Jun 10;384(23):2212-2218. doi: 10.1056/NEJMoa2105000. Epub 2021 Apr 21. N Engl J Med. 2021. PMID: 33882219 Free PMC article.

References

    1. Dyer O. Covid-19: Chinese vaccines may need changes to improve efficacy, admits official. BMJ. 2021;373:n969. doi: 10.1136/bmj.n969. - DOI - PubMed
    1. Hacisuleyman E., Hale C., Saito Y., Blachere N.E., Bergh M., Conlon E.G., et al. Vaccine breakthrough infections with SARS-CoV-2 variants. N Engl J Med. 2021 doi: 10.1056/NEJMoa2105000. 0:null. - DOI - PMC - PubMed
    1. Selingerova I., Valik D., Gescheidtova L., Sramek V., Cermakova Z., Zdrazilova-Dubska L. Interpretive discrepancies caused by target values inter-batch variations in chemiluminescence immunoassay for SARS-CoV-2 IgM/IgG by MAGLUMI. J Med Virol. 2021;93 doi: 10.1002/jmv.26612. 1805–9. - DOI - PubMed